Gene · 5515
Papers3,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phosphoprotein phosphatase activity positively regulates oligomeric pyrin to trigger inflammasome assembly in phagocytes. | mBio | 2023 | 37787552 | PubTator, text mining | PubMed |
| Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases. | Medicina (Kaunas) | 2023 | 37763671 | PubTator, text mining | PubMed |
| Advanced Optical Microscopy: Unveiling Functional Insights Regarding a Novel PPP2R1A Variant and Its Unreported Phenotype. | Int J Mol Sci | 2023 | 37762002 | PubTator, text mining | PubMed |
| Novel Variants of PPP2R1A in Catalytic Subunit Binding Domain and Genotype-Phenotype Analysis in Neurodevelopmentally Delayed Patients. | Genes (Basel) | 2023 | 37761890 | Swiss-Prot, curated | PubMed |
| Phosphorylation of axin within biomolecular condensates counteracts its tankyrase-mediated degradation. | J Cell Sci | 2023 | 37721093 | PubTator, text mining | PubMed |
| Microsomal glutathione transferase 1 in cancer and the regulation of ferroptosis. | Adv Cancer Res | 2023 | 37704286 | PubTator, text mining | PubMed |
| Cryo-EM structures of PP2A:B55-FAM122A and PP2A:B55-ARPP19. | bioRxiv | 2023 | 37693408 | PubTator, text mining | PubMed |
| Striatins and STRIPAK complex partners in clinical outcomes of patients with breast cancer and responses to drug treatment. | Chin J Cancer Res | 2023 | 37691891 | PubTator, text mining | PubMed |
| JNK Cascade-Induced Apoptosis-A Unique Role in GqPCR Signaling. | Int J Mol Sci | 2023 | 37686335 | PubTator, text mining | PubMed |
| Identification of co-diagnostic effect genes for aortic dissection and metabolic syndrome by multiple machine learning algorithms. | Sci Rep | 2023 | 37684281 | PubTator, text mining | PubMed |
| Antitumor mechanism of Saikosaponin A in the Xiaoying Sanjie Decoction for treatment of anaplastic thyroid cancer by network pharmacology analysis and experiments in vitro and in vivo. | Fitoterapia | 2023 | 37673277 | PubTator, text mining | PubMed |
| Editorial: Deciphering the etiology of rare genetic disorders associated with protein phosphatases. | Front Cell Dev Biol | 2023 | 37645249 | PubTator, text mining | PubMed |
| Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance. | Nat Commun | 2023 | 37644036 | PubTator, text mining | PubMed |
| Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure. | BMC Biol | 2023 | 37635218 | PubTator, text mining | PubMed |
| A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d. | Cancers (Basel) | 2023 | 37627221 | PubTator, text mining | PubMed |
| NEK8 regulates colorectal cancer progression via phosphorylating MYC. | Cell Commun Signal | 2023 | 37596667 | PubTator, text mining | PubMed |
| The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain. | Blood Cancer J | 2023 | 37591861 | PubTator, text mining | PubMed |
| Quantitative proteomics and phosphoproteomics of PP2A-PPP2R5D variants reveal deregulation of RPS6 phosphorylation via converging signaling cascades. | J Biol Chem | 2023 | 37572851 | PubTator, text mining | PubMed |
| Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds. | Cancers (Basel) | 2023 | 37568796 | PubTator, text mining | PubMed |
| R-loop-dependent promoter-proximal termination ensures genome stability. | Nature | 2023 | 37557913 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5515/papers?page=7